Developer docs
API playgroundTry for free, no card

Search company profiles

Formative Pharma

Full company profile

uuid000mxxk

Namestring
Formative Pharma
Legal namestring
Formative Pharma Inc.
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Formative Pharma Inc. is a privately held Canadian specialty pharmaceutical company founded in 2018 and headquartered in Burlington, Ontario. The company specializes in the development, registration, and commercialization of Health Canada-approved sterile injectable pharmaceuticals and medical devices for the Canadian market, excluding Quebec. Its portfolio comprises nine distinct formulations across four therapeutic categories: local anesthetics (Lidocaine Hydrochloride 1% and 2% in vial and ampoule presentations; Bupivacaine Hydrochloride in Dextrose 0.75% for spinal anesthesia), antivirals (Ganciclovir), anticoagulants (Bivalirudin), and antineoplastic agents (Fulvestrant for breast cancer; Cabazitaxel in 4.5 mL and 6 mL vial presentations for prostate cancer). Products are positioned as value-add alternatives to incumbent brand-name drugs (Xylocaine, Marcaine, Cytovene, Angiomax, Faslodex) with features including preservative-free formulations, latex-free container systems, and unit-of-use 2D barcodes with variable data and GTINs for supply-chain traceability.

The company operates a sales-led go-to-market model targeting hospitals and pharmacies across Canada, distributing through two major pharmaceutical wholesalers — McKesson Canada and the Canadian Pharmaceutical Distribution Network (CPDN) — with direct customer service and an online ordering platform for institutional buyers. Revenue is generated primarily through per-unit product sales (hardware-style model), supplemented by a co-pay assistance program that provides eligible patients with up to 20% financial support, administered through Auxilium Health. Marketing is digital-first, using the corporate website, LinkedIn, product monographs, and healthcare-professional-targeted educational content (including a co-developed video series with Infusion Excellence Consulting on elastomeric device use). The company is led by founder Lee Mangubat (President & CEO), with Lauren Barth as COO and Karen Patrick as EVP of Scientific Affairs; the executive team collectively brings 150+ years of sterile pharmaceutical experience. No institutional funding rounds, M&A activity, or AI/ML capabilities are disclosed in the available data.

Short descriptiontext

Formative Pharma is a privately held Canadian specialty pharmaceutical company that develops, registers, and commercializes Health Canada-approved sterile injectable pharmaceuticals and medical devices, supplying hospitals and pharmacies across Canada (excluding Quebec) through wholesalers such as McKesson Canada and CPDN.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBurlington, Canada
HQ citystring
Burlington
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceuticals, pharmaceutical injectables, sterile injectables, medical devices, drug commercialization
Industry2 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceutical Injectables
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeHardware Sales
Description

Revenue generated from the sale of Health Canada approved pharmaceutical injectables and medical devices to hospitals and pharmacies across Canada. The company commercializes a portfolio of specialty products including local anesthetics, antivirals, anticoagulants, and antineoplastic agents.

formativepharma.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Co-Pay Assistance Program - up to 20% support
ModelOtherBilling cadencePay-as-you-go
Notes

Eligible patients receive immediate financial support of up to 20% for listed medications. Can be applied independently or alongside private or commercial insurance coverage. Administered through Auxilium Health.

formativepharma.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Formative Pharma develops, registers, and commercializes Health Canada approved specialty pharmaceutical injectables and medical devices for the Canadian market. The portfolio spans local anesthetics (Lidocaine, Bupivacaine), antivirals (Ganciclovir), antineoplastic agents (Fulvestrant, Cabazitaxel), and anticoagulants (Bivalirudin), sold to hospitals and pharmacies through direct sales and wholesale distribution channels. The company also offers a Co-Pay Assistance Program providing up to 20% financial support to eligible patients on listed medications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Growing portfolio of Health Canada approved pharmaceutical injectables and medical devices focused on quality of life enhancement for Canadians.
Product overview1 text field

Formative Pharma is a Canadian pharmaceutical company specializing in Health Canada-approved pharmaceutical injectables and medical devices. The product portfolio consists of nine distinct sterile injectable formulations: Lidocaine Hydrochloride (1% and 2%) in both vial and ampoule presentations for local anesthesia; Bupivacaine Hydrochloride in Dextrose 0.75% hyperbaric solution for spinal anesthesia; Ganciclovir antiviral powder for injection; Fulvestrant estrogen receptor antagonist pre-filled syringe for breast cancer; Bivalirudin direct thrombin inhibitor powder for injection; and Cabazitaxel antineoplastic agent (4.5 mL and 6 mL vials) for prostate cancer treatment. Products are distributed with full traceability including DINs, GTINs, and 2D barcodes with variable data. The company also operates a Co-Pay Program providing up to 20% financial assistance for eligible medications.

Product and service9 records
1Lidocaine Hydrochloride Injection USP 1% (10 mg/mL, 5 mL Vial)
CategoryPharmaceutical Injectables - Local Anesthetics
Description

Local anesthetic for infiltration and nerve block procedures. Preservative-free formulation with latex-free vial stopper. Health Canada approved.

2Lidocaine Hydrochloride Injection USP 1% (10 mg/mL, 5 mL Ampoule)
CategoryPharmaceutical Injectables - Local Anesthetics
Description

Local anesthetic for infiltration and nerve block procedures in ampoule presentation. Preservative-free formulation. Packaged as 25 x 5 mL ampoules per carton.

3Lidocaine Hydrochloride Injection USP 2% (20 mg/mL, 5 mL Vial)
CategoryPharmaceutical Injectables - Local Anesthetics
Description

Higher concentration local anesthetic for infiltration and nerve block procedures. Preservative-free formulation with latex-free vial stopper. Brand reference: Xylocaine.

4Ganciclovir for Injection (500 mg/vial, 10 mL Vial)
CategoryPharmaceutical Injectables - Antivirals
Description

Antiviral sterile powder for solution for injection, indicated for the treatment of CMV (cytomegalovirus) infections. Brand reference: Cytovene. Packaged as 25 vials per carton. Features 2D barcode with variable data, GTIN, preservative-free formulation, and latex-free vial stopper.

5Fulvestrant Injection (50 mg/mL, 5 mL Pre-filled Syringe)
CategoryPharmaceutical Injectables - Antineoplastics
Description

Non-steroidal estrogen receptor antagonist for the treatment of breast cancer. Sterile solution in a pre-filled syringe. Brand reference: FASLODEX. Components in contact with drug product solution are latex-free.

6Bupivacaine Hydrochloride in Dextrose Injection USP 0.75% (7.5 mg/mL, 2 mL Ampoule)
CategoryPharmaceutical Injectables - Local Anesthetics
Description

Sterile hyperbaric local anesthetic solution for spinal anesthesia. Brand reference: Marcaine. Packaged as 10 x 2 mL ampoules per carton.

7Bivalirudin for Injection (250 mg/vial, 10 mL Vial)
CategoryPharmaceutical Injectables - Anticoagulants
Description

Direct thrombin inhibitor anticoagulant for intravenous use. Sterile powder for solution. Brand reference: Angiomax. Packaged as 10 x 250 mg vials per carton.

8Cabazitaxel for Injection (10 mg/mL, 4.5 mL Vial)
CategoryPharmaceutical Injectables - Antineoplastics
Description

Antineoplastic agent for intravenous infusion used in prostate cancer treatment. Single-dose vial formulation.

9Cabazitaxel for Injection (10 mg/mL, 6 mL Vial)
CategoryPharmaceutical Injectables - Antineoplastics
Description

Antineoplastic agent for intravenous infusion used in prostate cancer treatment. Vial secured with plastic sleeve and bottom puck. Brand reference: SANDOZ.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Infusion Excellence Consulting
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-10-27
Description

Partnership for development of educational video content on elastomeric devices. Includes a two-part video series for nurses demonstrating how to effectively teach patients to independently use elastomeric devices, and a four-part video series for patients with step-by-step instructions on safe usage of elastomeric devices.

formativepharma.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Formative Pharma

Specialty Pharmaceutical Injectablesformativepharma.com

Formative Pharma is a privately held Canadian specialty pharmaceutical company that develops, registers, and commercializes Health Canada-approved sterile injectable pharmaceuticals and medical devices, supplying hospitals and pharmacies across Canada (excluding Quebec) through wholesalers such as McKesson Canada and CPDN.

What Formative Pharma does

Formative Pharma Inc. is a privately held Canadian specialty pharmaceutical company founded in 2018 and headquartered in Burlington, Ontario. The company specializes in the development, registration, and commercialization of Health Canada-approved sterile injectable pharmaceuticals and medical devices for the Canadian market, excluding Quebec. Its portfolio comprises nine distinct formulations across four therapeutic categories: local anesthetics (Lidocaine Hydrochloride 1% and 2% in vial and ampoule presentations; Bupivacaine Hydrochloride in Dextrose 0.75% for spinal anesthesia), antivirals (Ganciclovir), anticoagulants (Bivalirudin), and antineoplastic agents (Fulvestrant for breast cancer; Cabazitaxel in 4.5 mL and 6 mL vial presentations for prostate cancer). Products are positioned as value-add alternatives to incumbent brand-name drugs (Xylocaine, Marcaine, Cytovene, Angiomax, Faslodex) with features including preservative-free formulations, latex-free container systems, and unit-of-use 2D barcodes with variable data and GTINs for supply-chain traceability.

The company operates a sales-led go-to-market model targeting hospitals and pharmacies across Canada, distributing through two major pharmaceutical wholesalers — McKesson Canada and the Canadian Pharmaceutical Distribution Network (CPDN) — with direct customer service and an online ordering platform for institutional buyers. Revenue is generated primarily through per-unit product sales (hardware-style model), supplemented by a co-pay assistance program that provides eligible patients with up to 20% financial support, administered through Auxilium Health. Marketing is digital-first, using the corporate website, LinkedIn, product monographs, and healthcare-professional-targeted educational content (including a co-developed video series with Infusion Excellence Consulting on elastomeric device use). The company is led by founder Lee Mangubat (President & CEO), with Lauren Barth as COO and Karen Patrick as EVP of Scientific Affairs; the executive team collectively brings 150+ years of sterile pharmaceutical experience. No institutional funding rounds, M&A activity, or AI/ML capabilities are disclosed in the available data.

Formative Pharma firmographics

Firmographics
Name
Formative Pharma
Legal name
Formative Pharma Inc.
Website
https://formativepharma.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
Formative Pharma is a privately held Canadian specialty pharmaceutical company that develops, registers, and commercializes Health Canada-approved sterile injectable pharmaceuticals and medical devices, supplying hospitals and pharmacies across Canada (excluding Quebec) through wholesalers such as McKesson Canada and CPDN.
Ownership category
akta.pro rank

Formative Pharma industry classification

Industry
Product category
Specialty Pharmaceutical Injectables
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRAOAHAK
Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops)

Keywords

  • Specialty pharmaceuticals
  • Pharmaceutical injectables
  • Sterile injectables
  • Medical devices
  • Drug commercialization

Where Formative Pharma is headquartered

Location

Headquarters

HQ city
Burlington
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Formative Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Product Sales: Revenue generated from the sale of Health Canada approved pharmaceutical injectables and medical devices to hospitals and pharmacies across Canada. The company commercializes a portfolio of specialty products including local anesthetics, antivirals, anticoagulants, and antineoplastic agents.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goCo-Pay Assistance Program - up to 20% support

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Formative Pharma product offering

Product offering

Core offering

Formative Pharma develops, registers, and commercializes Health Canada approved specialty pharmaceutical injectables and medical devices for the Canadian market. The portfolio spans local anesthetics (Lidocaine, Bupivacaine), antivirals (Ganciclovir), antineoplastic agents (Fulvestrant, Cabazitaxel), and anticoagulants (Bivalirudin), sold to hospitals and pharmacies through direct sales and wholesale distribution channels. The company also offers a Co-Pay Assistance Program providing up to 20% financial support to eligible patients on listed medications.

Product overview

Formative Pharma is a Canadian pharmaceutical company specializing in Health Canada-approved pharmaceutical injectables and medical devices. The product portfolio consists of nine distinct sterile injectable formulations: Lidocaine Hydrochloride (1% and 2%) in both vial and ampoule presentations for local anesthesia; Bupivacaine Hydrochloride in Dextrose 0.75% hyperbaric solution for spinal anesthesia; Ganciclovir antiviral powder for injection; Fulvestrant estrogen receptor antagonist pre-filled syringe for breast cancer; Bivalirudin direct thrombin inhibitor powder for injection; and Cabazitaxel antineoplastic agent (4.5 mL and 6 mL vials) for prostate cancer treatment. Products are distributed with full traceability including DINs, GTINs, and 2D barcodes with variable data. The company also operates a Co-Pay Program providing up to 20% financial assistance for eligible medications.

Differentiator

Problem solved

Functional benefit

Products and services

  • Lidocaine Hydrochloride Injection USP 1% (10 mg/mL, 5 mL Vial) Local anesthetic for infiltration and nerve block procedures. Preservative-free formulation with latex-free vial stopper. Health Canada approved.
  • Lidocaine Hydrochloride Injection USP 1% (10 mg/mL, 5 mL Ampoule) Local anesthetic for infiltration and nerve block procedures in ampoule presentation. Preservative-free formulation. Packaged as 25 x 5 mL ampoules per carton.
  • Lidocaine Hydrochloride Injection USP 2% (20 mg/mL, 5 mL Vial) Higher concentration local anesthetic for infiltration and nerve block procedures. Preservative-free formulation with latex-free vial stopper. Brand reference: Xylocaine.
  • Ganciclovir for Injection (500 mg/vial, 10 mL Vial) Antiviral sterile powder for solution for injection, indicated for the treatment of CMV (cytomegalovirus) infections. Brand reference: Cytovene. Packaged as 25 vials per carton. Features 2D barcode with variable data, GTIN, preservative-free formulation, and latex-free vial stopper.
  • Fulvestrant Injection (50 mg/mL, 5 mL Pre-filled Syringe) Non-steroidal estrogen receptor antagonist for the treatment of breast cancer. Sterile solution in a pre-filled syringe. Brand reference: FASLODEX. Components in contact with drug product solution are latex-free.
  • Bupivacaine Hydrochloride in Dextrose Injection USP 0.75% (7.5 mg/mL, 2 mL Ampoule) Sterile hyperbaric local anesthetic solution for spinal anesthesia. Brand reference: Marcaine. Packaged as 10 x 2 mL ampoules per carton.
  • Bivalirudin for Injection (250 mg/vial, 10 mL Vial) Direct thrombin inhibitor anticoagulant for intravenous use. Sterile powder for solution. Brand reference: Angiomax. Packaged as 10 x 250 mg vials per carton.
  • Cabazitaxel for Injection (10 mg/mL, 4.5 mL Vial) Antineoplastic agent for intravenous infusion used in prostate cancer treatment. Single-dose vial formulation.
  • Cabazitaxel for Injection (10 mg/mL, 6 mL Vial) Antineoplastic agent for intravenous infusion used in prostate cancer treatment. Vial secured with plastic sleeve and bottom puck. Brand reference: SANDOZ.

Quantifiable outcome

  • Growing portfolio of Health Canada approved pharmaceutical injectables and medical devices focused on quality of life enhancement for Canadians.

Companies that use Formative Pharma

Customer profile

Segments3 records

Ideal customer profiles3 records

Formative Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Formative Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Infusion Excellence ConsultingcoreStrategic or Co-development Partner · 27 October 2021Partnership for development of educational video content on elastomeric devices. Includes a two-part video series for nurses demonstrating how to effectively teach patients to independently use elastomeric devices, and a four-part video series for patients with step-by-step instructions on safe usage of elastomeric devices.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Formative Pharma competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Formative Pharma social profiles

Digital presence

Formative Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Formative Pharma leadership team

Management profile

Number of profiles

Profiles3 records

Formative Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Formative Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Formative Pharma

What does Formative Pharma do?

Formative Pharma develops, registers, and commercializes Health Canada approved specialty pharmaceutical injectables and medical devices for the Canadian market. The portfolio spans local anesthetics (Lidocaine, Bupivacaine), antivirals (Ganciclovir), antineoplastic agents (Fulvestrant, Cabazitaxel), and anticoagulants (Bivalirudin), sold to hospitals and pharmacies through direct sales and wholesale distribution channels. The company also offers a Co-Pay Assistance Program providing up to 20% financial support to eligible patients on listed medications.

Is Formative Pharma a public or private company?

Formative Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Formative Pharma founded?

Formative Pharma was founded in 2018. It employs 11 to 50 people.

Where is Formative Pharma based?

Formative Pharma is headquartered in Burlington, Canada, in the North America region.

How does Formative Pharma make money?

One revenue line is on record: pharmaceutical Product Sales.

Does Formative Pharma have an API?

No public API is recorded for Formative Pharma.

What industry is Formative Pharma in?

Formative Pharma's product category is Specialty Pharmaceutical Injectables. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of CRAOAHAK, Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales